Curtana Pharmaceuticals Company

Curtana is a biopharmaceutical company that has developed therapies for the treatment of the most aggressive types of brain cancer.


Investors

Total Funding: 52288
Headquarters: Austin, Texas, United States
Funding Status: Seed
Employee Number: 1-10
Estimated Revenue: Less than $1M
Last Funding Type: Grant
Technology: Small Molecules
Investor Type: Seed
Last Funding Date: 2017
Investors Number: 3
Founded Date: 2013
Industry: Biopharma, Biotechnology, Pharmaceutical